Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 17, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Temporal bone myeloid sarcoma.

Ki-Hong Chang1, Dong-Kee Kim, Beom-Cho Jun

  • 1Department of Otorhinolaryngology, The Catholic University of Korea School of Medicine, Seoul, Korea.

Clinical and Experimental Otorhinolaryngology
|January 15, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mucoadhesive polydopamine-coated nanoparticle-mediated inner ear drug delivery for hearing loss treatment.

Journal of translational medicine·2025
Same author

Recent Advances in Functionalized Nanoparticles for Targeted and Controlled Inner Ear Therapy via Localized Cochlear Delivery.

Journal of audiology & otology·2025
Same author

The effects of candidate probiotic strains on the gut environment in dextran sulfate sodium-induced colitis mouse.

Scientific reports·2025
Same author

Morphometric analysis of the internal auditory canal by developmental change using three-dimensional computed tomography.

Surgical and radiologic anatomy : SRA·2024
Same author

A sensorineural hearing loss harboring novel compound heterozygous variant in the <i>TRIOBP</i> gene: A case report.

Heliyon·2024
Same author

Dexamethasone nanocrystals-embedded hydroxypropyl methylcellulose hydrogel increases cochlear delivery and attenuates hearing loss following intratympanic injection.

Carbohydrate polymers·2024

Myeloid sarcoma in the temporal bone, a rare condition involving immature myeloid cells, can mimic otomastoiditis. Early diagnosis via MRI is crucial for remission, with high-dose therapies offering the best cure potential.

Area of Science:

  • Oncology
  • Hematology
  • Radiology

Background:

  • Myeloid sarcoma is a rare extramedullary tumor of immature myeloid cells.
  • Temporal bone involvement is more common with myeloid sarcoma than other metastatic lesions.
  • Symptoms can mimic otomastoiditis, complicating diagnosis.

Purpose of the Study:

  • To describe clinical features of myeloid sarcoma in the temporal bone.
  • To compare these features with metastatic lesions in the temporal bone.
  • To highlight the role of MRI in diagnosis and staging.

Main Methods:

  • Case series of 5 patients with temporal bone myeloid sarcoma.
  • Comparison of clinical features with patients having metastatic lesions.
  • Review of diagnostic utility of Magnetic Resonance Imaging (MRI).
Keywords:
Myeloid sarcomaTemporal bone

More Related Videos

High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology
03:42

High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology

Published on: May 18, 2022

Related Experiment Videos

Last Updated: Jun 17, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology
03:42

High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology

Published on: May 18, 2022

Main Results:

  • Myeloid sarcoma frequently involves the mastoid bone.
  • MRI is effective for diagnosing and staging temporal bone myeloid sarcoma.
  • Early diagnosis is critical for achieving remission.

Conclusions:

  • Myeloid sarcoma in the temporal bone requires prompt diagnosis and treatment.
  • High-dose radio- or chemotherapy are primary treatment modalities for remission and cure.
  • Understanding the distinct presentation of myeloid sarcoma is vital for effective management.